Tracers / [18F]MK-6240

[18F]MK-6240

Also written as [18F]MK-6240; [18F]MK6240; [F-18]MK-6240; [F-18]MK6240; F-18 MK-6240; F-18 MK6240; F-18-MK6240
Radionuclide
F-18 t½ 109.7 min
Modality
PET
Production route
Cyclotron liquid target
Stage
Approved
Syntheses indexed
2

What it is

Compound class
Small molecule
Target / mechanism
Aggregated tau (neurofibrillary tangles) PMID 28185305 / DOI 10.1002/jlcr.3496
Clinical application
Detection of tau (neurofibrillary-tangle) pathology in Alzheimer's disease PMID 28185305 / DOI 10.1002/jlcr.3496
Theranostic pair

Regulatory status

FDA
Yes — 2026; TAUKLARIFY (florquinitau F 18); Cerveau Technologies / Lantheus; NDA 220496 Drugs@FDA, NDA 220496, approved 2026-08-13 — https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process&searchTerm=florquinitau
EMA (centralised)
Other approvals
Brand names
Tauklarify (US, FDA)

Clinical use

Typical injected activity
Uptake time
Brain PET acquired ~90-110 min after injection (dynamic and dual-time-window protocols also used) PMID 41591778 / DOI 10.1001/jamanetworkopen.2025.54524

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
HPLC9.8% ± 1.8%
yes
N-[(tert-butoxy)carbonyl]-N-(6-nitro-3-[1H-pyrrolo[2,3-c]pyridin-1-yl]isoquinolin-5-yl) carbamate30426529
2019 J Labelled Comp Radiopharm
The synthesis was performed automatically with a single-use cassette on an IBA Synthera+ synthesis module. — resulting in an isolated radiochemical yield of 9.8% ± 1.8% (n = 3) calculated from the end of bombardment (5.2% ± 1.0% calculated from the end of synthesis).
HPLC7.5% ± 1.9%
no
5-diBoc-6-nitro precursor28185305
2017 J Labelled Comp Radiopharm
a commercially available radiosynthesis module, GE Healthcare TRACERlab FXFN — in an uncorrected radiochemical yield of 7.5% ± 1.9% (relative to starting [18 F]fluoride)

Precursor

Common precursor
Bis-Boc-protected 6-nitro precursor; nucleophilic [18F]fluorination (SNAr displacing the nitro group) then acid deprotection and HPLC PMID 28185305
Suppliers seen in the literature
Typical final purification

Need this precursor?We can point you to suppliers for [18F]MK-6240, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
USP monograph
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]MK-6240.

Get in touch

Notes

Added at user request.